Vis enkel innførsel

dc.contributor.authorThorkildsen, Joachim
dc.contributor.authorTaksdal, Ingeborg
dc.contributor.authorBjerkehagen, Bodil
dc.contributor.authorHaugland, Hans Kristian
dc.contributor.authorJohannessen, Tom Børge
dc.contributor.authorViset, Trond
dc.contributor.authorNorum, Ole-Jacob Anderssen
dc.contributor.authorBruland, Øyvind
dc.contributor.authorZaikova, Olga
dc.date.accessioned2021-02-11T15:42:15Z
dc.date.available2021-02-11T15:42:15Z
dc.date.created2019-03-05T18:28:55Z
dc.date.issued2019
dc.identifier.citationActa Oncologica. 2019, 1-10.en_US
dc.identifier.issn0284-186X
dc.identifier.urihttps://hdl.handle.net/11250/2727508
dc.description.abstractBackground: Knowledge of chondrosarcoma (CS) of bone to date is based on institutional reports and registry publications with limits in reporting, detail and quality of data. Method: We have performed a retrospective search of CS of bone in the National Cancer Registry in Norway from 1990-2013, cross checked against local tumor databases with further quality control and supplementation of all data from clinical files. The time period is defined by the routine use of axial imaging in clinical practice. 311 cases are included. We performed 108 pathological reviews and 223 radiological reviews. The manuscript is prepared according to the STROBE checklist for strengthening of observational studies. We perform uni-/multivariate cox analysis to define independent prognostic variables from the main cohort of central CS of bone. Results: The incidence of CS of bone in Norway is 2.85/million/yr. for both sexes overall, rising to 3.45/million/yr. in the last 5 year period. There is an increase in the most common central CS subtype, stronger for women than for men. Central CS has, in general 10-15% local recurrence rates, all evident by 5 years while metastasis rate increases with location and grade. Exceptions are extremity grade 1 CS which displayed no metastatic events and axial grade 3 disease with high rates (50%) of both local and metastatic relapse. Peripheral CS has limited metastatic potential (2%) but rates of local relapse (13%) continue to appear towards 10 years of follow up. Malignancy grade 3 independently predicts rate of metastasis and presence of soft tissue component predicts local recurrence, metastasis and survival. Conclusion: Rates of local recurrence, metastasis and disease specific survival follow clear patterns depending on subtype, location and grade allowing better tailoring of follow up regimes. Malignancy grade 3 and presence of a soft tissue component independently predict behaviour for central CS of bone.en_US
dc.language.isoengen_US
dc.publisherTaylor & Francisen_US
dc.titleChondrosarcoma in Norway 1990-2013; an epidemiological and prognostic observational study of a complete national cohorten_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionacceptedVersionen_US
dc.source.pagenumber1-10en_US
dc.source.volume58en_US
dc.source.journalActa Oncologicaen_US
dc.identifier.doi10.1080/0284186X.2018.1554260
dc.identifier.cristin1682493
dc.description.localcodeThis is the authors accepted manuscrip of the article published in Acta Oncologica, https://doi.org/10.1080/0284186X.2018.1554260en_US
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel